Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies-Reference-Cited by-同舟云学术

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies

Published:2022-07 Issue:5 Volume:6 Page:e12760
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Chowdary Pratima,Holmström Margareta,Mahlangu Johnny N.,Ozelo Margaret C.,Pabinger Ingrid^ORCID,Pasi K. John,Ragni Margaret V.,Shapiro Amy,Barnowski Chris,Lethagen Stefan

Funder

Sanofi

Swedish Orphan Biovitrum

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12760

Reference70 articles.

1. The role of orthopedic surgery in hemophilia: current rationale, indications and results;Rodríguez‐Merchán;EFORT Open Rev,2019

2. Perioperative clotting factor replacement and infection in total knee arthroplasty;Wong;Haemophilia,2012

3. Outcome of perioperative hemostatic management in patients with hemophilia without inhibitors undergoing 161 invasive or surgical procedures;Tong;J Chin Med Assoc,2018

4. WFH guidelines for the management of hemophilia, 3rd edition;Srivastava;Haemophilia,2020

5. Invasive procedures in patients with hemophilia: review of low‐dose protocols and experience with extended half‐life FVIII and FIX concentrates and non‐replacement therapies;Hermans;Haemophilia,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Management of Hemophilia Patients;Current Anesthesiology Reports;2024-06-14

2. Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review;Journal of Thrombosis and Haemostasis;2024-04

3. Recombinant factor IX Fc for the treatment of hemophilia B;European Journal of Haematology;2024-02-18

4. Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single‐centre, real‐world experience of surgery;Haemophilia;2023-12-27

5. Clinical pharmacology of emicizumab for the treatment of hemophilia A;Expert Review of Clinical Pharmacology;2023-08-21